Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Current Biology : CB|September 19, 2006
CRACM1 multimers form the ion-selective pore of the CRAC channelMonika Vig, Andreas Beck, James M Billingsley, et al.
Oncoimmunology|January 27, 2017
Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapyHenoch S Hong, Sven D Koch, Birgit Scheel, et al.
Plos Pathogens|March 14, 2015
Characterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profilingJames M Billingsley, Premeela A Rajakumar, Michelle A Connole, et al.
Journal of Virology|February 23, 2018
Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus MacaquesDiane Carnathan, Benton Lawson, Joana Yu, et al.
Scientific Reports|May 19, 2021
Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approachLindsay T Fourman, Takara L Stanley, James M Billingsley, et al.
JCI Insight|July 24, 2020
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLDLindsay T Fourman, James M Billingsley, George Agyapong, et al.
Ebiomedicine|April 25, 2018
Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus VectorsSteven Tuyishime, Larissa H Haut, Raj K Kurupati, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2021
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver DiseaseTakara L Stanley, Lindsay T Fourman, Lai Ping Wong, et al.
JCI Insight|March 10, 2022
Lymph node CXCR5+ NK cells associate with control of chronic SHIV infectionSheikh Abdul Rahman, James M Billingsley, Ashish Arunkumar Sharma, et al.
Plos Pathogens|August 25, 2018
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replicationKrystelle Nganou-Makamdop, James M Billingsley, Zachary Yaffe, et al.
Pageof 3